Study Assessing Immunogenicity and Safety of IC43 In Intensive Care Patients

Clinical trial NCT00876252 · COMPLETED

Trial details

NCT number: NCT00876252
Sponsor: Valneva Austria GmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pneumonia, Ventilator-Associated

Start date: 2008-12-01
Primary completion: 2010-02-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.